Beating the odds: extreme long-term survival with glioblastoma
Authors:
- 5 August 2014
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 16 (9) , 1159-1160
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed GlioblastomaNew England Journal of Medicine, 2014
- An extent of resection threshold for newly diagnosed glioblastomasJournal of Neurosurgery, 2011
- A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiformeJournal of Neurosurgery, 2010
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesisCancer Cell, 2006
- Long survival and therapeutic responses in patient histologically disparate high-grade gliomas demonstrating chromosome 1p lossJournal of Neurosurgery, 2000